Natasha Elsner

[Natasha Elsner @UsmanovaElsner]

@gunsnrosesgirl3 Jazz

[Natasha Elsner @UsmanovaElsner]

@UREssien @PittCP3 @DMGrayMD @DusetzinaS @ChatterjeePaula @PittTweet @JayCdoesID @NYCHealthCMO @cvspharmacy @Arnold_Ventures @ETSshow Post this on LinkedIn too! A lot of folks became less active on Twitter

[Natasha Elsner @UsmanovaElsner]

@DrugChannels @Walgreens @HeatherLandi @FierceHealth Would love to see commentary on clinic economics or how Walgreens expects to make primary care more efficient and profitable than it is today

[Natasha Elsner @UsmanovaElsner]

Is it possible to incorporate premature deaths in budget impact calculations? #askaeihealth

[Natasha Elsner @UsmanovaElsner]

@DrugChannels @Blueberry_Rx @medsavers @martyschladen Maybe, more employers should pay attention. Carving out generics might be a viable rx benefit strategy.

[Natasha Elsner @UsmanovaElsner]

@UREssien @statnews Love the term pharmacoequity and thanks for the A-B-C action steps!

[Natasha Elsner @UsmanovaElsner]

@DrugChannels @A_Ciaccia @46brooklyndata Even Anthem felt outgunned and outsmarted in their dealings with ES, despite considerable resources and sophistication that state Medicaid programs probably lack.

[Natasha Elsner @UsmanovaElsner]

Who would think an article about birds would feature the terms "culture" and "innovation"... https://t.co/PKUWX5Wf9j

[Natasha Elsner @UsmanovaElsner]

@DrugChannels @Costco Wonder how much of the overspending could be classified as waste vs. value. Is there value in competition and patient access to a pharmacy of their choice? Is there value in integrated view of all patients' drugs - something payers often claim?

[Natasha Elsner @UsmanovaElsner]

@DrugChannels @darreldrowland @DispatchAlerts Thank you for sharing. Thorough reporting, indeed

[Natasha Elsner @UsmanovaElsner]

@chrissyfarr Is there an actionable step or treatment, or only a risk? if the consequences from knowing the risks are not immediate, it’s fair to assume you will switch health insurances by the time the risk translates into a need for treatment. The average churn is 2-3 years, right?

[Natasha Elsner @UsmanovaElsner]

@chrissyfarr And in previous years, we have seen that exposure to cost information is more influential on physician behavior than they think. See figure 3 here https://t.co/L64icOD8iH

[Natasha Elsner @UsmanovaElsner]

@chrissyfarr Most physicians in the Deloitte survey agree that education about the business of medicine should be taught in med school. We cite this statistic in figure 2. https://t.co/Q6VGtEXEqF

[Natasha Elsner @UsmanovaElsner]

@jpelzer Participate in her hobbies even if you don’t want to, like dance lessons.

[Natasha Elsner @UsmanovaElsner]

The Deloitte Center for Health Solutions surveyed #healthcare leaders to understand their concerns, approaches, and steps to resume non-urgent procedures. Discover their post- #COVID-19 insights. https://t.co/mAi1eIG2PG

[Natasha Elsner @UsmanovaElsner]

How can #digital technologies transform the way companies approach clinical development? @DeloitteInsight weighs-in.
https://t.co/X6YITDh3cv

[Natasha Elsner @UsmanovaElsner]

@PHLAirport how soon can we expect Term A situation resolved